(19)
(11) EP 2 089 521 A1

(12)

(43) Date of publication:
19.08.2009 Bulletin 2009/34

(21) Application number: 07776571.7

(22) Date of filing: 01.05.2007
(51) International Patent Classification (IPC): 
C12N 15/12(2006.01)
C12N 15/11(2006.01)
A61K 48/00(2006.01)
A61P 29/00(2006.01)
C07K 14/715(2006.01)
A61K 38/17(2006.01)
C07H 21/00(2006.01)
(86) International application number:
PCT/US2007/010556
(87) International publication number:
WO 2008/051306 (02.05.2008 Gazette 2008/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 20.10.2006 US 862350 P
10.11.2006 WO PCT/US2006/000436

(71) Applicants:
  • Ercole Biotech, Inc.
    Research Triangle Park, NC 27709 (US)
  • The University of North Carolina At Chapel Hill
    Chapel Hill NC 27599-4105 (US)

(72) Inventors:
  • SAZANI, Peter L.
    Chapel Hill, NC 27514 (US)
  • GRAZIEWICZ, Maria
    Chapel Hill, NC 27514 (US)
  • KOLE, Ryszard
    Chapel Hill, NC 27514 (US)

(74) Representative: Peterreins, Frank 
Fish & Richardson P.C. Highlight BusinessTowers Mies-van-der-Rohe-Strasse 8
80807 München
80807 München (DE)

   


(54) SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE